PharmacoEconomics & Outcomes News

, Volume 781, Issue 1, pp 4–4 | Cite as

ICER review finds abaloparatide and teriparatide too costly

News item
  • 14 Downloads

Reference

  1. Institute for Clinical and Economic Review. Institute for Clinical and Economic Review report finds inadequate evidence to distinguish between anabolic therapies for osteoporosis. Internet Document : 16 Jun 2017. Available from: URL: https://icer-review.org/announcements/osteo-evidence-report/

Copyright information

© Springer International Publishing AG  2017

Personalised recommendations